CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell...
Phase 2
Cleveland, Ohio, United States and 83 other locations
in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...
Phase 3
Cleveland, Ohio, United States and 209 other locations
This is a phase 3 study to evaluate zimberelimab (AB122) combined with domvanalimab (AB154) compared to pembrolizumab in front-line, PD-L1-high, loca...
Phase 3
Cleveland, Ohio, United States and 167 other locations
PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung cancer (NSCLC)....
Phase 2
Cleveland, Ohio, United States and 126 other locations
This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...
Phase 2
Cleveland, Ohio, United States and 123 other locations
and in combination with pembrolizumab in patients with advanced non-small cell lung cancer and colorecta...
Phase 1
Cleveland, Ohio, United States and 13 other locations
This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over...
Phase 2
Cleveland, Ohio, United States and 252 other locations
Stage IB, IIA, IIB, IIIA, or selected IIIB resectable and untreated non-small cell lung cancer (NSCLC) t...
Phase 2
Cleveland, Ohio, United States and 33 other locations
, early-stage non-small cell lung cancer....
Phase 2
Cleveland, Ohio, United States and 94 other locations
Phase 1 open label dose ranging study of RH324 in advanced non-small cell lung cancer...
Phase 1
Cleveland, Ohio, United States
Clinical trials
Research sites
Resources
Legal